CLSABNCT07880860
Cleft Lip Scarring After Botox
At risk: Primary endpoint(s) modified.
See at-risk trials from Children's National Research Institute
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary endpoint(s) modified
- Secondary endpoint revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (1)
Arms and interventions
Participants undergoing cleft lip repair receive intraoperative botulinum toxin type A injections at the time of surgical repair. Scar outcomes and adverse events are assessed during postoperative follow-up.
Participants undergoing cleft lip repair receive intraoperative placebo (normal saline) injections at the time of surgical repair. Scar outcomes and adverse events are assessed during postoperative follow-up.
Drugs: Botulinum Toxin Type A (BOTOX) Injection, Normal Saline
Sites
1 site in 1 country
- Children's National HospitalWashington D.C., District of Columbia, United States